Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Law of Segregation01:49

Law of Segregation

When crossing pea plants, Mendel noticed that one of the parental traits would sometimes disappear in the first generation of offspring, called the F1 generation, and could reappear in the next generation (F2). He concluded that one of the traits must be dominant over the other, thereby causing masking of one trait in the F1 generation. When he crossed the F1 plants, he found that 75% of the offspring in the F2 generation had the dominant phenotype, while 25% had the recessive phenotype.
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Bioequivalence studies: Biowaivers01:13

Bioequivalence studies: Biowaivers

In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mind Everywhere: A Framework for Conceptualizing Goal-Directedness in Biology and Other Domains-Part One.

Biological theory·2026
Same author

Mind Everywhere: A Framework for Conceptualizing Goal-Directedness in Biology and Other Domains-Part Two.

Biological theory·2026
Same author

Assessing the Environmental Risks of Health Research Leads to Problematic Mission Creep for Ethics Committees.

The American journal of bioethics : AJOB·2026
Same author

Conflicts of Interest, Funding Support, and Author Affiliation in Peer-Reviewed Research on the Relationship between Climate Change and Geophysical Characteristics of Hurricanes.

Bulletin of the American Meteorological Society·2026
Same author

The Vicious Spiral of AI Slop: Uncurated machine-generated content threatens research integrity and trust in science, ultimately harming all of us.

American scientist·2026
Same author

Transparent Journal Review of Dual Use Research of Concern.

Health security·2026

Related Experiment Video

Updated: Jul 6, 2026

High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents (HPHC)
11:38

High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents (HPHC)

Published on: May 10, 2016

Patents and the research exemption

David B Resnik

    Science (New York, N.Y.)
    |February 8, 2003
    PubMed
    Summary

    No abstract available in PubMed .

    More Related Videos

    Disposable Dosators for Pulmonary Insufflation of Therapeutic Agents to Small Animals
    04:22

    Disposable Dosators for Pulmonary Insufflation of Therapeutic Agents to Small Animals

    Published on: March 30, 2017

    Refined Murine Model of Idiopathic Pulmonary Fibrosis
    07:51

    Refined Murine Model of Idiopathic Pulmonary Fibrosis

    Published on: June 17, 2025

    Related Experiment Videos

    Last Updated: Jul 6, 2026

    High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents (HPHC)
    11:38

    High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents (HPHC)

    Published on: May 10, 2016

    Disposable Dosators for Pulmonary Insufflation of Therapeutic Agents to Small Animals
    04:22

    Disposable Dosators for Pulmonary Insufflation of Therapeutic Agents to Small Animals

    Published on: March 30, 2017

    Refined Murine Model of Idiopathic Pulmonary Fibrosis
    07:51

    Refined Murine Model of Idiopathic Pulmonary Fibrosis

    Published on: June 17, 2025